11 Induction of multinucleation in infected host cells by a Chlamydia trachomatis inclusion membrane protein

Maria Silva Filipe Pequito Luís UCIBIO – NOVA School of Science and Technology ms.luis@campus.fct.unl.pt Catarina Simões1,2,3, Luís Jaime Mota1,2 1Associate Laboratory i4HB – Institute for Health and Bioeconomy, NOVA School of Science and Technology, NOVA University Lisbon, Caparica, Portugal. 2UCIBIO – Applied Molecular Biosciences Unit, Department of Life Sciences, NOVA School of Science and Technology,… Continue reading 11 Induction of multinucleation in infected host cells by a Chlamydia trachomatis inclusion membrane protein

10 Evaluation of methicillin-resistant Staphylococcus aureus carriage in the elderly in Portugal using selective enrichment followed by qPCR

Sónia Margarida Tavares Matos Almeida Laboratory of Molecular Microbiology of Human Pathogens, Instituto de Tecnologia Química e Biológica António Xavier Universidade Nova de Lisboa (ITQB NOVA) soniaalmeida@itqb.unl.pt Ana C. Paulo, LMMHP, ITQB NOVA, Oeiras, Portugal; Hermínia de Lencastre, Laboratory of Molecular Genetics, ITQB NOVA, Oeiras, Portugal; and Laboratory of Microbiology and Infectious Diseases, The Rockefeller… Continue reading 10 Evaluation of methicillin-resistant Staphylococcus aureus carriage in the elderly in Portugal using selective enrichment followed by qPCR

9 Pneumococcal carriage among Portuguese children after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in the National Immunization Plan

Catarina Isabel Brandão Candeias Laboratory of Molecular Microbiology of Human Pathogens, Instituto de Tecnologia Química e Biológica António Xavier Universidade Nova de Lisboa (ITQB NOVA) candeias@itqb.unl.pt Sónia T. Almeida*, LMMHP, ITQB NOVA, Oeiras, Portugal; Alexandra S. Simões*, LMMHP, ITQB NOVA, Oeiras, Portugal; Bárbara Ferreira, LMMHP, ITQB NOVA, Oeiras, Portugal; Ana Raquel Cruz, LMMHP, ITQB NOVA,… Continue reading 9 Pneumococcal carriage among Portuguese children after the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) in the National Immunization Plan